EW vs. ROP
EW (Edwards Lifesciences Corporation) and ROP (Roper Technologies, Inc.) are both stocks. EW operates in Medical Devices (Healthcare), while ROP operates in Specialty Industrial Machinery (Industrials). Over the past 10 years, EW returned 9.72%/yr vs 7.73%/yr for ROP. At a 0.34 correlation, their price movements are largely independent.
Performance
EW vs. ROP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EW achieves a -0.16% return, which is significantly higher than ROP's -24.40% return. Over the past 10 years, EW has outperformed ROP with an annualized return of 9.72%, while ROP has yielded a comparatively lower 7.73% annualized return.
EW
- 1D
- -0.76%
- 1M
- 4.58%
- YTD
- -0.16%
- 6M
- 2.44%
- 1Y
- 13.25%
- 3Y*
- -0.88%
- 5Y*
- -3.17%
- 10Y*
- 9.72%
ROP
- 1D
- 0.68%
- 1M
- 4.38%
- YTD
- -24.40%
- 6M
- -24.53%
- 1Y
- -39.80%
- 3Y*
- -9.19%
- 5Y*
- -5.54%
- 10Y*
- 7.73%
EW vs. ROP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EW Edwards Lifesciences Corporation | -0.16% | 15.16% | -2.91% | 2.20% | -42.41% | 42.00% | 17.32% | 52.31% | 35.90% | 20.29% |
ROP Roper Technologies, Inc. | -24.40% | -13.85% | -4.11% | 26.92% | -11.64% | 14.69% | 22.39% | 33.66% | 3.51% | 42.39% |
Correlation
The correlation between EW and ROP is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.40 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.41 |
Correlation (All Time) Calculated using the full available price history since Mar 27, 2000 | 0.34 |
The correlation between EW and ROP shifts across timeframes, from 0.14 (1 year) to 0.41 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
EW:
$49.42B
ROP:
$35.04B
EW:
$1.87
ROP:
$15.98
EW:
45.49
ROP:
20.96
EW:
1.46
ROP:
2.48
EW:
7.89
ROP:
4.43
EW:
4.79
ROP:
1.86
EW:
$6.30B
ROP:
$8.12B
EW:
$4.92B
ROP:
$5.63B
EW:
$1.44B
ROP:
$3.24B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EW vs. ROP — Risk / Return Rank
EW
ROP
EW vs. ROP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and Roper Technologies, Inc. (ROP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EW | ROP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.15 | ||
| Sortino ratioReturn per unit of downside risk | +3.30 | ||
| Omega ratioGain probability vs. loss probability | 1.11 | 0.70 | +0.41 |
| Calmar ratioReturn relative to maximum drawdown | 0.96 | -0.92 | +1.88 |
| Martin ratioReturn relative to average drawdown | 2.37 | -1.51 | +3.87 |
Loading charts...
Drawdowns
EW vs. ROP - Drawdown Comparison
The maximum EW drawdown since its inception was -54.32%, smaller than the maximum ROP drawdown of -58.94%. Use the drawdown chart below to compare losses from any high point for EW and ROP.
Loading charts...
Drawdown Indicators
| EW | ROP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -54.32% | -58.94% | +4.62% |
Max Drawdown (1Y)Largest decline over 1 year | -12.73% | -44.65% | +31.92% |
Max Drawdown (3Y)Largest decline over 3 years | -37.53% | -46.51% | +8.98% |
Max Drawdown (5Y)Largest decline over 5 years | -54.32% | -46.51% | -7.81% |
Max Drawdown (10Y)Largest decline over 10 years | -54.32% | -46.51% | -7.81% |
Current DrawdownCurrent decline from peak | -34.87% | -43.07% | +8.20% |
Average DrawdownAverage peak-to-trough decline | -14.48% | -11.43% | -3.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.15% | 27.25% | -22.10% |
Volatility
EW vs. ROP - Volatility Comparison
The current volatility for Edwards Lifesciences Corporation (EW) is 6.36%, while Roper Technologies, Inc. (ROP) has a volatility of 8.14%. This indicates that EW experiences smaller price fluctuations and is considered to be less risky than ROP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EW | ROP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.36% | 8.14% | -1.78% |
Volatility (6M)Calculated over the trailing 6-month period | 18.73% | 21.59% | -2.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.12% | 25.08% | -0.96% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.60% | 21.39% | +11.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.25% | 23.34% | +8.91% |
Dividends
EW vs. ROP - Dividend Comparison
EW has not paid dividends to shareholders, while ROP's dividend yield for the trailing twelve months is around 1.04%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EW Edwards Lifesciences Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ROP Roper Technologies, Inc. | 1.04% | 0.74% | 0.58% | 0.50% | 0.57% | 0.46% | 0.48% | 0.52% | 0.62% | 0.54% | 0.66% | 0.53% |
Financials
EW vs. ROP - Financials Comparison
This section allows you to compare key financial metrics between Edwards Lifesciences Corporation and Roper Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EW vs. ROP - Profitability Comparison
EW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported a gross profit of 1.29B and revenue of 1.65B. Therefore, the gross margin over that period was 78.2%.
ROP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Roper Technologies, Inc. reported a gross profit of 1.45B and revenue of 2.10B. Therefore, the gross margin over that period was 69.4%.
EW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported an operating income of 514.70M and revenue of 1.65B, resulting in an operating margin of 31.2%.
ROP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Roper Technologies, Inc. reported an operating income of 569.60M and revenue of 2.10B, resulting in an operating margin of 27.2%.
EW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported a net income of 380.70M and revenue of 1.65B, resulting in a net margin of 23.1%.
ROP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Roper Technologies, Inc. reported a net income of 508.90M and revenue of 2.10B, resulting in a net margin of 24.3%.
Frequently Asked Questions
EW and ROP have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ROP has higher volatility (8.14%) compared to EW (6.36%). In terms of maximum drawdown, EW dropped -54.32% vs ROP's -58.94%.
EW currently has the higher Sharpe Ratio (0.51 vs -1.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EW and ROP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer